Filing Details
- Accession Number:
- 0001110803-13-000124
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-22 18:36:41
- Reporting Period:
- 2013-03-20
- Filing Date:
- 2013-03-22
- Accepted Time:
- 2013-03-22 18:36:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1539796 | Marc Stapley | 5200 Illumina Way San Diego CA 92122 | Sr Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-20 | 711 | $36.30 | 29,237 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-03-20 | 711 | $53.00 | 28,526 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-03-20 | 1,422 | $36.30 | 29,948 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-03-20 | 1,422 | $52.53 | 28,526 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-03-20 | 711 | $0.00 | 711 | $36.30 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-03-20 | 1,422 | $0.00 | 1,422 | $36.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
131,321 | 2013-01-20 | 2022-01-20 | No | 4 | M | Direct |
129,899 | 2013-01-20 | 2022-01-20 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.